beovu - brolucizumab injection, solution
(Brolucizumab)Novartis Pharmaceuticals Corporation
Usage: BEOVU is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME).
Medications for Macular Edema Due To Diabetes Mellitus
6 results
cimerli - ranibizumab - eqrn injection, solution
(Ranibizumab-Eqrn)Coherus Biosciences IncUsage: Cimerli treats neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.eylea hd - aflibercept injection, solution
(Aflibercept)Regeneron Pharmaceuticals, IncUsage: EYLEA HD treats neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), diabetic retinopathy (DR), and macular edema following retinal vein occlusion (RVO).lucentis - ranibizumab injection, solution
(Ranibizumab)Genentech, Inc.Usage: Lucentis treats neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.susvimo - ranibizumab injection, solution
(Ranibizumab)Genentech, Inc.Usage: Susvimo (ranibizumab) treats neovascular (wet) age-related macular degeneration, diabetic macular edema, and diabetic retinopathy in patients who have previously responded to at least two intravitreal VEGF inhibitor injections.vabysmo - faricimab injection, solution
(Faricimab)Genentech, Inc.Usage: Vabysmo treats neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO) by inhibiting VEGF and angiopoietin-2.